[SCENARIO] id=107 | sector=health | agents=3 | rounds=20
[AGENTS] 1=Quality & Patient Safety Director, 2=Pharmacy Informatics Lead, 3=Hospital Finance & Operations Director
[GOAL] Produce a final recommendation on whether to approve and fund a 60-day corrective action plan to raise inpatient medication reconciliation reliability at admission and discharge, balancing regulatory deadlines, patient-safety impact, workflow feasibility, and financial/operational constraints.

[R0.1] Quality & Patient Safety Director (speak, public): To effectively move forward with our corrective action plan, we need to ensure that we are fully aligned on the resource implications and operational feasibility. I would like to share our baseline compliance audit results showing that we only have a 71% completion rate for admission medication reconciliation and 62% for discharge. We also have identified that unclear ownership contributes to 43% of our defects. Given the Joint Commission requirement, we have 45 days to show evidence of compliance. Can we discuss the potential resource footprint and scheduling feasibility of the proposed changes?
[R0.2] Pharmacy Informatics Lead (speak, public): I appreciate the baseline compliance results you've shared, and I agree that aligning on resource implications will be crucial for our corrective action plan. To ensure we have a comprehensive understanding, I can share our current medication reconciliation workflow, which includes six steps and averages 18 minutes for pharmacist verification. I believe this will help us identify areas where we can improve efficiency. Additionally, I would like to discuss the urgency of our next steps and any specific success expectations tied to external oversight. Can we also clarify any potential organizational pressures that might affect our approach?
[R0.3] Hospital Finance & Operations Director (speak, public): To ensure we align on the resource implications, I’d like to share that our contracted pharmacist coverage rate is $92 per hour, with a minimum commitment of 20 hours a week. Considering the urgency of our corrective action plan, we should assess how this rate impacts our financial viability. Additionally, it’s essential we quantify the scale of change needed and any potential operational strain indicators that could arise during implementation. Can we gather insights on these aspects?

[R1.1] Quality & Patient Safety Director (speak, public): To build on our discussion and ensure we are aligned, I would like to emphasize the need to clarify the practical scope of the changes we are proposing. Specifically, could we discuss the potential hidden capacity limits we might face and how they could affect our scheduling feasibility? This understanding will be crucial as we move forward with the corrective action plan.
[R1.2] Pharmacy Informatics Lead (speak, public): I understand the urgency and the importance of clarifying the practical scope of the proposed changes. To facilitate our discussion, I can share that we are considering a discharge hard-stop for 'Reconcile and Sign' in the EHR, which would require an estimated build effort of 120 hours and a testing cycle of two weeks. Additionally, I propose a microlearning module for training, aimed at 850 learners, which would take about 15 minutes to complete. This could help streamline our workflow and address some of the inefficiencies we've identified. Can we also delve deeper into the specific resource implications and any hidden capacity limits we might face during implementation?
[R1.3] Hospital Finance & Operations Director (speak, public): To ensure we make informed decisions moving forward, I would like to stress the importance of assessing any operational strain indicators we might encounter, such as overtime or vacancies that could affect our execution risk. Additionally, can we gather any insights on the financial viability assessment of the corrective action plan? Understanding these factors will be crucial to our recommendation on funding the 60-day plan.

[R2.1] Quality & Patient Safety Director (speak, public): I appreciate the insights shared regarding the discharge hard-stop and the microlearning module. To ensure we can effectively implement these changes, I propose we conduct a thorough assessment of our current operational capacity and resource allocation to identify any hidden constraints. Let's also prioritize clarifying the financial viability of the corrective action plan to align it with our safety improvements. Can we schedule a follow-up meeting to dive deeper into these aspects?
[R2.2] Pharmacy Informatics Lead (leave, public): 
[R2.3] Hospital Finance & Operations Director (leave, public): 

[R3.1] Quality & Patient Safety Director (leave, public): 
[R3.2] Pharmacy Informatics Lead (leave, public): 
[R3.3] Hospital Finance & Operations Director (leave, public): 

[R4.1] Quality & Patient Safety Director (leave, public): 
[R4.2] Pharmacy Informatics Lead (leave, public): 
[R4.3] Hospital Finance & Operations Director (leave, public): 

[R5.1] Quality & Patient Safety Director (leave, public): 
[R5.2] Pharmacy Informatics Lead (leave, public): 
[R5.3] Hospital Finance & Operations Director (leave, public): 

[R6.1] Quality & Patient Safety Director (leave, public): 
[R6.2] Pharmacy Informatics Lead (leave, public): 
[R6.3] Hospital Finance & Operations Director (leave, public): 

[R7.1] Quality & Patient Safety Director (leave, public): 
[R7.2] Pharmacy Informatics Lead (leave, public): 
[R7.3] Hospital Finance & Operations Director (leave, public): 

[R8.1] Quality & Patient Safety Director (leave, public): 
[R8.2] Pharmacy Informatics Lead (leave, public): 
[R8.3] Hospital Finance & Operations Director (leave, public): 

[R9.1] Quality & Patient Safety Director (leave, public): 
[R9.2] Pharmacy Informatics Lead (leave, public): 
[R9.3] Hospital Finance & Operations Director (leave, public): 

[R10.1] Quality & Patient Safety Director (leave, public): 
[R10.2] Pharmacy Informatics Lead (leave, public): 
[R10.3] Hospital Finance & Operations Director (leave, public): 

[R11.1] Quality & Patient Safety Director (leave, public): 
[R11.2] Pharmacy Informatics Lead (leave, public): 
[R11.3] Hospital Finance & Operations Director (leave, public): 

[R12.1] Quality & Patient Safety Director (leave, public): 
[R12.2] Pharmacy Informatics Lead (leave, public): 
[R12.3] Hospital Finance & Operations Director (leave, public): 

[R13.1] Quality & Patient Safety Director (leave, public): 
[R13.2] Pharmacy Informatics Lead (leave, public): 
[R13.3] Hospital Finance & Operations Director (leave, public): 

[R14.1] Quality & Patient Safety Director (leave, public): 
[R14.2] Pharmacy Informatics Lead (leave, public): 
[R14.3] Hospital Finance & Operations Director (leave, public): 

[R15.1] Quality & Patient Safety Director (leave, public): 
[R15.2] Pharmacy Informatics Lead (leave, public): 
[R15.3] Hospital Finance & Operations Director (leave, public): 

[R16.1] Quality & Patient Safety Director (leave, public): 
[R16.2] Pharmacy Informatics Lead (leave, public): 
[R16.3] Hospital Finance & Operations Director (leave, public): 

[R17.1] Quality & Patient Safety Director (leave, public): 
[R17.2] Pharmacy Informatics Lead (leave, public): 
[R17.3] Hospital Finance & Operations Director (leave, public): 

[R18.1] Quality & Patient Safety Director (leave, public): 
[R18.2] Pharmacy Informatics Lead (leave, public): 
[R18.3] Hospital Finance & Operations Director (leave, public): 

[R19.1] Quality & Patient Safety Director (leave, public): 
[R19.2] Pharmacy Informatics Lead (leave, public): 
[R19.3] Hospital Finance & Operations Director (leave, public): 

